Clinical Trials - PULM

NCT IDTitleStatusPhasesStart DateCompletion DatePrimary Completion Date
NCT05667662Study to Evaluate Itraconazole Administered as Inhaled Dry Powder in Adults With Asthma and ABPATERMINATEDPHASE22023-02-012024-02-272024-02-27
NCT05351086A Study to Assess the Safety, Tolerability, and Pharmacokinetics of PUR3100 in Health AdultsCOMPLETEDPHASE12022-06-092022-09-222022-09-22
NCT04759807A Phase 1b Study of PUR1800 in Patients With COPDCOMPLETEDPHASE12021-01-042021-12-022021-12-02
NCT03960606Study in Adult Asthmatic Patients With Allergic Bronchopulmonary AspergillosisTERMINATEDPHASE22019-07-312020-07-142020-07-14
NCT03479411Safety, Tolerability and Pharmacokinetics of PUR1900 (Itraconazole Powder) in Healthy Volunteers and Adults With AsthmaCOMPLETEDPHASE12018-02-092018-06-282018-06-28
NCT02671825A PK Study to Evaluate PUR0200 and a Reference Product in Healthy SubjectsCOMPLETEDPHASE12016-012016-032016-03
NCT02280395A Phase I/II Double-Blind, Randomized, Controlled Study to Evaluate the Safety and Efficacy of RUT058-60TERMINATEDPHASE1, PHASE22014-102015-062015-06
NCT0219896321 Day Cumulative Skin Irritation of RUT058-60COMPLETEDPHASE12014-072014-092014-08
NCT01921712A Safety, Pharmacokinetic and Pharmacodynamic Study of PUR0200 in COPD PatientsCOMPLETEDPHASE12013-072013-122013-12
NCT01690949Evaluation of the Effect of PUR118 on Ozone Induced Airway Inflammation in Healthy Normal VolunteersCOMPLETEDPHASE12012-082013-042013-04
NCT01543191A Safety and Tolerability Study OF PUR118 In Subjects With Cystic FibrosisCOMPLETEDPHASE12012-022012-122012-12
NCT01333904Safety, Tolerability, and Pharmacodynamic Effect Study of PUR118COMPLETEDPHASE12011-022012-062012-06
NCT00989521Effect of PUR003 on AsthmaCOMPLETEDPHASE12009-122011-102011-10
NCT00947687Safety and Efficacy Study of Inhaled PUR003 on a Controlled Influenza Virus Challenge in Healthy Adult SubjectsCOMPLETEDPHASE12009-072009-102009-09